HTG Molecular Diagnostics, Inc. (HTGM)

NASDAQ: HTGM · IEX Real-Time Price · USD
1.06
+0.02 (1.92%)
At close: Aug 15, 2022 4:00 PM
1.01
-0.05 (-4.72%)
After-hours: Aug 15, 2022 7:55 PM EDT
1.92%
Market Cap 11.71M
Revenue (ttm) 8.07M
Net Income (ttm) -22.07M
Shares Out 11.05M
EPS (ttm) -2.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 296,395
Open 1.00
Previous Close 1.04
Day's Range 0.98 - 1.10
52-Week Range 0.46 - 6.98
Beta 1.28
Analysts Buy
Price Target 3.83 (+261.3%)
Earnings Date Aug 11, 2022

About HTGM

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus as... [Read more...]

Industry Health Care Technology
IPO Date May 6, 2015
CEO John Lubniewski
Employees 87
Stock Exchange NASDAQ
Ticker Symbol HTGM
Full Company Profile

Financial Performance

In 2021, HTGM's revenue was $8.91 million, an increase of 4.19% compared to the previous year's $8.55 million. Losses were -$17.15 million, -17.85% less than in 2020.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for HTGM stock is "Buy." The 12-month stock price forecast is 3.83, which is an increase of 261.32% from the latest price.

Price Target
$3.83
(261.32% upside)
Analyst Consensus: Buy
Stock Forecasts

News

HTG Molecular Diagnostics to Announce Q2 2022 Financial Results and Host Conference Call on Thursday, August 11

TUCSON, Ariz., Aug. 04, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profi...

HTG Molecular Diagnostics Hosting a KOL Event Addressing Drug Candidate Attrition

TUCSON, Ariz., July 19, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profi...

REV, CSSE: The Top 5 Short Squeeze Stocks to Watch This Week

Short squeeze stocks are still hot among retail traders and we're helping them out with a list of companies to watch this week! The post REV, CSSE: The Top 5 Short Squeeze Stocks to Watch This Week appe...

Other symbols: MICSBHATCSSEREV

HTG Molecular Diagnostics Announces Amendment to Senior Loan Facility

TUCSON, Ariz., July 18, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profi...

HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery

TUCSON, Ariz., July 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profi...

Publication Highlights Potential Clinical Applications of the HTG Transcriptome Panel in Bladder Cancer

TUCSON, Ariz., June 29, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profi...

HTG to Sponsor Keynote Presentation Featuring Customer Use of its HTG EdgeSeq Technology in Clinical Trials

TUCSON, Ariz., June 08, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profi...

HTG Technology Featured in Multiple Scientific Abstracts Highlighting Novel Applications in Precision Medicine at ASC...

TUCSON, Ariz., June 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profi...

HTG Molecular Diagnostics to Participate in the H.C. Wainwright Global Investment Conference

TUCSON, Ariz., May 17, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profil...

HTG Molecular Diagnostics, Inc. (HTGM) Reports Q1 Loss, Lags Revenue Estimates

HTG Molecular Diagnostics, Inc. (HTGM) delivered earnings and revenue surprises of -14.08% and 15.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for th...

HTG Molecular Diagnostics Reports First Quarter 2022 Results

Call scheduled for today, May 12, at 4:30 pm ET Call scheduled for today, May 12, at 4:30 pm ET

HTG Expands Therapeutics Team

Christina M. Carruthers, Ph.D. Joins as Vice President of Target Strategy and Early Development Christina M. Carruthers, Ph.D. Joins as Vice President of Target Strategy and Early Development

HTG Expands Features of Proprietary HTG EdgeSeq Technology

New Sample Preparation Harmonization Designed to Enable miRNA and mRNA Profiling Without the Need for Additional Sample New Sample Preparation Harmonization Designed to Enable miRNA and mRNA Profiling W...

HTG Releases Proof-of-Approach Whitepaper Establishing Utility of Transcriptome-Informed Approach to Drug Discovery

TUCSON, Ariz., March 31, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide prof...

HTG Molecular Diagnostics Reports Full Year 2021 Results

Call scheduled for today, March 29, at 4:30 pm ET Call scheduled for today, March 29, at 4:30 pm ET

HTG Molecular Diagnostics Announces $7.5 Million Private Placement

TUCSON, Ariz., March 18, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has...

HTG Names Renowned RNA Expert Dr. Robert Spitale to Therapeutics Scientific Advisory Board

TUCSON, Ariz., Feb. 03, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profi...

HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors

Brings Significant Operational Experience in Building Therapeutic Drug Development Businesses Brings Significant Operational Experience in Building Therapeutic Drug Development Businesses

HTG Molecular Diagnostics Announces Certain Preliminary 2021 Unaudited Financial Results

Preliminary full year 2021 unaudited revenue of $8.9 million

HTG Completes HTP Product Next-Phase Development Milestone

Expands Potential Market and Study Opportunities for HTG Transcriptome Panel Expands Potential Market and Study Opportunities for HTG Transcriptome Panel

HTG Expands Therapeutics Scientific Advisory Board With Addition of Dr. Jerald Radich

Renowned Physician-Scientist Brings Significant Expertise as a Pioneer in the Fields of Leukemia Research and Molecular Genetics Renowned Physician-Scientist Brings Significant Expertise as a Pioneer in...

HTG and Icahn School of Medicine at Mount Sinai Announce Bladder Cancer Research Collaboration

HTG's Innovative Transcriptome Panel Technology to be Leveraged in Retrospective Studies HTG's Innovative Transcriptome Panel Technology to be Leveraged in Retrospective Studies

HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TUCSON, Ariz., Nov. 15, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profi...

Preview: HTG Molecular Diagnostics's Earnings

HTG Molecular Diagnostics (NASDAQ:HTGM) is set to give its latest quarterly earnings report on Wednesday, 2021-11-10. Here's what investors need to know before the announcement.

HTG Molecular Diagnostics to Present at H.C. Wainwright's 23rd Annual Global Investment Conference

TUCSON, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that compan...